Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 2017; Volume 91,Issue 4

Minireview

  • You have access
    Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
    Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
    Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151

Articles

  • You have access
    Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
    Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
    Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213
  • You have access
    Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States
    Sooyeon Jo and Bruce P. Bean
    Molecular Pharmacology April 2017, 91 (4) 277-286; DOI: https://doi.org/10.1124/mol.116.106401
  • You have access
    Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
    Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
    Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526
  • You have access
    Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization
    Marco A. Alfonzo-Méndez, David A. Hernández-Espinosa, Gabriel Carmona-Rosas, M. Teresa Romero-Ávila, Guadalupe Reyes-Cruz and J. Adolfo García-Sáinz
    Molecular Pharmacology April 2017, 91 (4) 296-306; DOI: https://doi.org/10.1124/mol.116.106583
  • You have access
    Trim13 Potentiates Toll-Like Receptor 2–Mediated Nuclear Factor κB Activation via K29-Linked Polyubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6
    Bin Huang and Suk-Hwan Baek
    Molecular Pharmacology April 2017, 91 (4) 307-316; DOI: https://doi.org/10.1124/mol.116.106716
  • You have access
    Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy
    Wenjuan Chen, Anel Tankovic, Pieter B. Burger, Hirofumi Kusumoto, Stephen F. Traynelis and Hongjie Yuan
    Molecular Pharmacology April 2017, 91 (4) 317-330; DOI: https://doi.org/10.1124/mol.116.106781
  • You have access
    AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
    Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
    Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623
  • You have access
    A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
    Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
    Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276
  • You have access
    Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1
    Yadav Wagley, Ping-Yee Law, Li-Na Wei and Horace H. Loh
    Molecular Pharmacology April 2017, 91 (4) 357-372; DOI: https://doi.org/10.1124/mol.116.106567
  • You have access
    Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling
    Emily V. Mesev, David S. Miller and Ronald E. Cannon
    Molecular Pharmacology April 2017, 91 (4) 373-382; DOI: https://doi.org/10.1124/mol.116.107169
  • You have access
    Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
    Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar and Karen S. Anderson
    Molecular Pharmacology April 2017, 91 (4) 383-391; DOI: https://doi.org/10.1124/mol.116.107755
  • You have access
    Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore
    Hai M. Nguyen, Vikrant Singh, Brandon Pressly, David Paul Jenkins, Heike Wulff and Vladimir Yarov-Yarovoy
    Molecular Pharmacology April 2017, 91 (4) 392-402; DOI: https://doi.org/10.1124/mol.116.108068
  • Open Access
    Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
    Sung Hye Kim, Oliver Pohl, Andre Chollet, Jean-Pierre Gotteland, Adam D. J. Fairhurst, Phillip R. Bennett and Vasso Terzidou
    Molecular Pharmacology April 2017, 91 (4) 403-415; DOI: https://doi.org/10.1124/mol.116.106013
  • You have access
    Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor
    Zara Y. Weinberg, Amanda S. Zajac, Tiffany Phan, Daniel J. Shiwarski and Manojkumar A. Puthenveedu
    Molecular Pharmacology April 2017, 91 (4) 416-427; DOI: https://doi.org/10.1124/mol.116.106633
  • You have access
    Divergent Mechanisms Leading to Signaling Dysfunction in Embryonic Muscle by Bisphenol A and Tetrabromobisphenol A
    Rui Zhang and Isaac N. Pessah
    Molecular Pharmacology April 2017, 91 (4) 428-436; DOI: https://doi.org/10.1124/mol.116.107342
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 91 (4)
Molecular Pharmacology
Vol. 91, Issue 4
1 Apr 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics